Conclusions
In the literature satisfying our inclusion criteria, GS, GH, and CS have individually shown inconsistent efficacy in decreasing OA pain and improving joint function. Many studies confirmed OA pain relief with glucosamine and CS use. The excellent safety profile of glucosamine and CS therapy should be discussed with patients, and these supplements may serve a role as an initial treatment modality for many OA patients.
References
1 N. Adachi, M. Ochi, M. Deie, Y. Ito and Y. Izuta, Lateral compartment osteoarthritis of the knee after meniscectomy treated by the transplantation of tissue-engineered cartilage and osteochondral plug, Arthroscopy 22 (2006), pp. 107–112. Abstract | View Record in Scopus | Cited By in Scopus (6)
2 G. Spahn, T. Mückley, E. Kahl and G.O. Hofmann, Factors affecting the outcome of arthroscopy in medial-compartment osteoarthritis of the knee, Arthroscopy 22 (2006), pp. 1233–1240. Abstract | View Record in Scopus | Cited By in Scopus (7)
3 M. Ikeuchi, T. Takahashi and T. Tani, Localized synovial hypertrophy in the anteromedial compartment of the osteoarthritic knee, Arthroscopy 21 (2005), pp. 1457–1461. Abstract | View Record in Scopus | Cited By in Scopus (6)
4 D.K. Bae, K.H. Yoon and S.J. Song, Cartilage healing after microfracture in osteoarthritic knees, Arthroscopy 22 (2006), pp. 367–374. Abstract | View Record in Scopus | Cited By in Scopus (13)
5 M.J. Stuart and J.H. Lubowitz, What, if any, are the indications for arthroscopic debridement of the osteoarthritic knee?, Arthroscopy 22 (2006), pp. 238–239. Abstract | View Record in Scopus | Cited By in Scopus (8)
6 US Senate Committee on Health, Education, Labor and Pensions, Subcommittee on Aging, Center for Disease Control's role in combating the burden of arthritis, Department of Health & Human Services, Washington, DC (2004).
7 J.F. Fries, C.A. Williams, D.A. Block and B.A. Michel, Nonsteroidal anti-inflammatory drug-associated gastropathy: Incidence and risk factor models, Am J Med 91 (1991), pp. 213–222. Abstract | View Record in Scopus | Cited By in Scopus (229)
8 J.J. Deeks, L.A. Smith and M.D. Bradley, Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: Systematic review of randomised controlled trials, BMJ 325 (2002), p. 619. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (210)
9 G. Vetter, Topical therapy of arthroses with glucosamine (Dona 200), Munch Med Wochenschr 11 (1969), pp. 1499–1502 (in German). View Record in Scopus | Cited By in Scopus (5)
10 J. Theodasksi, B. Adderly and B. Fox, The arthritis cure, St Martin's, New York, NY (1997).
11 L. Bucsi and G. Poór, Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis, Osteoarthritis Cartilage 6 (suppl A) (1998), pp. 31–36. Abstract | PDF (444 K) | View Record in Scopus | Cited By in Scopus (81)
12 P. Bourgeois, G. Chales, J. Dehais, B. Delcambre, J.L. Kuntz and S. Rozenberg, Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3 × 400 mg/day vs placebo, Osteoarthritis Cartilage 6 (1998), pp. 25–30. Abstract | PDF (433 K) | View Record in Scopus | Cited By in Scopus (76)
13 T. Conrozier, Anti-arthrosis treatments: Efficacy and tolerance of chondroitin sulfates (CS 4&6), Presse Med 27 (1998), pp. 1862–1865 (in French). View Record in Scopus | Cited By in Scopus (24)
14 B. Mazieres, B. Combe, A. Phan Van, J. Tondut and M. Grynfeltt, Chondroitin sulfate in osteoarthritis of the knee: A prospective, double blind, placebo controlled multicenter clinical study, J Rheumatol 28 (2001), pp. 173–181. View Record in Scopus | Cited By in Scopus (45)
15 B. Mazieres, M. Hucher, M. Zaim and P. Garnero, Effect of chondroitin sulfate in symptomatic knee osteoarthritis: A multicentre, randomised, double-blind, placebo-controlled study, Ann Rheum Dis 66 (2007), pp. 639–645. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (9)
16 D. Uebelhart, M. Malaise and R. Marcolongo et al., Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: A one year, randomized, double-blind, multicenter study versus placebo, Osteoarthritis Cartilage 12 (2004), pp. 269–276. Article | PDF (123 K) | View Record in Scopus | Cited By in Scopus (66)
17 P. Mathieu, Radiological progression of internal femoro-tibial osteoarthritis in gonarthrosis: Chondro-protective effect of chondroitin sulfates ACS4-ACS6, Presse Med 31 (2002), pp. 1386–1390 (in French). View Record in Scopus | Cited By in Scopus (9)